Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Tim not Tom (autocorrect)
I believed the BS purveyed by Drs. Saïd and Gershman on social media—and took their claims and professional standing to mean that this was a “load and lock” INVESTMENT. What an absolute clown show this turned out to be: they STILL—after 3+ years of “commercialization”—haven’t revealed BASIC information upon which investors make decisions (business plans with revenue streams, for example), NOTHING has been shown to generate business cash flows (including “Russia,” cachexia, and CaverStem), while instead they are piddling around selling “syringe kits” that they don’t even produce, and all the while the “business minds” drove this straight into the ground worse than the Hindenburg. Now the bellwether scientists who to my mind were the only basis for legitimacy here—Ichim and Patel—have resigned, leaving this clown car squarely in the hands of Tom Warbington and Don Dickerson (the aforementioned “business minds”)…
Second R/S in as many years. Followed by resignation of Drs. Ichim and Patel. Pure class and achievement by the “business minds” in this outfit…
And another at 1:150 in Feb 2020 (and had NOTHING to do with COVID)
As of yesterday’s low, deduct ANOTHER -50%
0:02a ET 12/3/2021 - Dow Jones
Creative Medical Shares Drop 40% After Public Offering Prices
Mentioned: CELZ
By Chris Wack
Creative Medical Technology Holdings Inc. shares were down 40% to $2.89 Friday after the company priced an underwritten public offering of about 3.9 million common shares and accompanying warrants to buy up to 3.9 million shares at a combined public offering price of $4.13.
The warrants have a per share exercise price of $4.13, are exercisable immediately, and expire five years from the date of issuance.
The proceeds from the offering are expected to total about $16 million, Creative Medical said.
The offering is expected to close on or about Tuesday, subject to customary closing conditions. The company has granted the underwriters of the offering a 45-day option to purchase up to 581,250 additional shares and/or additional warrants to purchase up to 581,250 shares to cover over-allotments, if any.
Creative Medical shares closed Thursday's session up 17%.
Write to Chris Wack at chris.wack@wsj.com
(END) Dow Jones Newswires
December 03, 2021 10:02 ET (15:02 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Caveat emptor. My own share count went from 5+ MILLION to *69*—no, that’s not a typo. Do you want to be invested in a company that “values” its shareholders like that? If they had something that would really drive revenues and profits, why didn’t they release it at any point over the last 4 years? Consider yourself amply warned…
Can we START—and FINALLY GET—clear exposition of business plans that contain DETAILED accounts of revenue streams, profit drivers (something fiscally meaningful, in terms of revenues and profits, beyond “kits”), and specific activities—of both a strategic and tactical nature—that are planned for DRIVING IMPROVEMENTS in these and related areas?
FDA approval, per se, doesn’t translate into sustained profits—hence the items listed above…
Almost half a million shares traded in the first 30 minutes today—they must be printing shares again…
4+-year, murky (at best), sans detailed business plan “temporary” strategies. Lol
“How low can ya go”…?
They’ve been saying that for 4+ years—during which time they have fleeced investors, released nothing that would drive the PPS naturally, and now have made themselves eligible for NASDAQ through TWO reverse splits in as many years—all on the backs of the shareholders responsible for the money they have and whom they claim to “value.”
Couldn’t they have built this ORGANICALLY—releasing news of whatever they have that is allegedly of value and letting the market take us up on its own naturally? Instead they try this “big reveal” strategy. Sadly nothing has changed in 4 years—other than the fact that a great many who is invested and commented here frequently are long gone…
They’ve had 3 years to show these—and have done SQUAT on that count. We shall see about the legal angle(s)
I’m contacting that law firm—and I encourage everyone else who lost money to consider doing the same. I’m certain there’s a case to be made
People that put their hard-earned money into what they believe is an investment, and read frequent social media posts from principally-involved professionals touting the efficacy of the company’s products—only to have their entire investment reduced to worthlessness—have every right to be PISSED.
Management skill matters. They have done NOTHING over the last 4 years but DESTROY shareholder value
Like our other friend said, this needs to hit several hundred PPS in order for me to feel ANYWHERE near whole. If they can’t do any better over the last 3+ years during “commercialization,” then the story IS over. If you have something valuable, you build it, you grow it, you capitalize: instead, this has done nothing but go down, down, DOWN.
It is a WORTHLESS FARCE (if it even deserves THAT name)! Again, my 5+ MILLION shares now stand at *69*. UNREAL—and the free-fall continues…
I’m quite frankly shocked not to have seen any activity related to potential class action lawsuits. I have outlined the basic argument, at least from my perspective, and would be happy to share with a law firm willing to take a class on based solely on contingency recovery…
100. Just read a few posts on this board—and move on to the next (REAL) investment…
Who knew that a company would be allowed to reverse-split its way onto the NASDAQ? Hopefully the application is denied. Bear in mind also the following 4 factors:
1. At $4.13 per share, that’s already dramatically lower than the effective price immediately following the MOST RECENT R/S.
2. The current EPS (-22.75 according to TDA) clearly reveals these R/Ss (for anyone who knows how to read financial reports OVER TIME). Take some simple numbers to demonstrate the point: -$50,000 earnings/1,000,000 outstanding shares= -$.05 EPS, while the same -$50,000 earnings/2,000 outstanding shares = -$25 EPS.
3. While it is true that a R/S, IN ITSELF, doesn’t change a shareholder’s ownership interest, when followed by subsequent DILUTION (such as we saw after the LAST R/S roughly two years ago, after which the OS again swelled to around 1.2 BILLION leading into the most recent R/S), one typically sees a DRAMATIC diminution of a shareholder’s ownership interest—as anyone who has experienced these R/Ss with CELZ can attest (assuming that they can analyze their way out of a wet paper sack). The linked article points to an IMMEDIATE addition of 3.875 million shares (DILUTION) to the current post R/S outstanding shares of around 2.45 million (according to TDA). Then, too, there is the warrant for an ADDITIONAL 3.875 million potentially to be added over the next 5 years.
4. Assuming the company has true profit potential, why would it not reveal that to the market over the course of the last 3-4 years—when massive dilution occurred, which led to the two R/Ss referenced above? Instead the developments described above occurred, more or less as outlined here—even as they proclaimed that “we delivered” and “value our shareholders.”
***Not financial advice, I’m merely pointing to historical patterns that can easily be uncovered by anyone who wishes to understand the HISTORICAL CONTEXT at play here. As always, I’m happy to be PROVEN wrong—but bring receipts, not hollow-ringing rhetoric: “in God we trust—all others bring data.” (Deming)
For many it does. Hint: ANY REAL institutional investor (investment-minded, not speculative) will DEMAND clear exposition of business plans that contain DETAILED accounts of revenue streams, profit drivers (and “kits” are essentially WORTHLESS as a driver of revenues and profits), and specific activities—of both a strategic and tactical nature—that are planned for DRIVING IMPROVEMENTS in these and related areas.
In over 3 years, this “management team” has delivered essentially NOTHING on this count, even as they claimed to “value their shareholders”—despite the fact that this kind of (a) content and (b) clear, consistent, compelling communication ABOUT that content are the ONLY way to promote PPS (which is the only TRUE, OBJECTIVE measure of concern for shareholders).
Couldn’t agree more: nice framing ??
Buyer beware: my shares have been hacked to ribbons—from 5M+ to *69* (yes, you read that right). Does a company that (a) has serious intrinsic value and/or (b) claims to care about and value its shareholders allow THAT to happen?
TDA currently shows the following, based on today’s action:
PPS: 0
Change: -.0003 (-99.75%)
Shares traded: 300
Is this company a shell, a toxic dumping ground for all that would otherwise ail a company like, for example, TS*I (which is owned by Dr. Ichim)? Please help me make sense if this madness after almost 4 years now…
These folks are conmen, if not outright criminals, plain and simple. Any professional—physician or otherwise—who associated with them has no care for reputation (or no reputation to care about).
PPS tanking AGAIN. Shocker…
5,250,000/150=35,000
35,000/500=70
All-star mgmt.
5M+ shares before, now 70. S-E-V-E-N-T-Y. Thanks for NOTHING, Tim and Don. You are MISERABLY inept business managers!
Good for you for asking questions ??
Like EVERYTHING ELSE over the last 3 years, the direct connections of these “advances” to REVENUE STREAMS for the company—and, by extension, its stockholders—are NOWHERE in sight (and probably not even contemplated). More detached, abstract “academic exercises”…
I wouldn’t DREAM of it: the wheels of justice grind (too) slowly, but I’ll be here to watch. Why should I be expected to leave my money meekly behind, like some simp OTC sheeple?
I’ve been beating the drum for them to show clear business plans, reliable revenue streams, etc—fundamental factors for REAL BUSINESSES—for over THREE YEARS.
If they had done so, it is reasonable to imagine that the first R/S (and maybe the upcoming second one) might never have been needed. Apparently they prefer to operate in an isolated vacuum and issue RARE pronouncements with the characteristic clarity of the Delphic Oracle. It truly defies every precept and reasonable expedition of logic and strategic business development.
Their reputation—including what is about to be the SECOND R/S in less than 2 years: 1:150 and now, at a minimum, 1:100 (that’s 1:15,000 for those keeping score at home)—will follow them EVERY step of the way. I’ll make sure of that…
You’re joking, right? Top of p. 6:
https://www.otcmarkets.com/filing/html?id=15157119&guid=XgW1ka4Zfvwkqth
The second was announced in a filing within the last 2 months—it was the basis for more “financing” and was to be effected within 90 days of the filing, as I recall.
I’m thinking that the second R/S in less than 2 years has something to do with that